Synergistic Effects of A Combined Treatment of Glioblastoma U251 Cells with An Anti-miR-10b-5p Molecule and An AntiCancer Agent Based on 1-(3′,4′,5′-Trimethoxyphenyl)-2-Aryl-1H-Imidazole Scaffold

(1) Background: In the development of new and more effective anticancer approaches, combined treatments appear of great interest. Combination therapy could be of importance in the management of glioblastoma (GBM), a lethal malignancy that accounts for 42% of cancer of the central nervous system, wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zurlo, Matteo, Romagnoli, Romeo, Oliva, Paola, Gasparello, Jessica, Finotti, Alessia, Gambari, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181338/
https://www.ncbi.nlm.nih.gov/pubmed/35682670
http://dx.doi.org/10.3390/ijms23115991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181338/
https://www.ncbi.nlm.nih.gov/pubmed/35682670
http://dx.doi.org/10.3390/ijms23115991

Ejemplares similares